author_facet Katafuchi, Takeshi
Katafuchi, Takeshi
author Katafuchi, Takeshi
spellingShingle Katafuchi, Takeshi
Bioscience Reports
Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
Cell Biology
Molecular Biology
Biochemistry
Biophysics
author_sort katafuchi, takeshi
spelling Katafuchi, Takeshi 0144-8463 1573-4935 Portland Press Ltd. Cell Biology Molecular Biology Biochemistry Biophysics http://dx.doi.org/10.1042/bsr20130025 <jats:p>In this study, Tyr808 in GC-B (guanylate cyclase-B), a receptor of the CNP (C-type natriuretic peptide), has been shown to be a critical regulator of GC-B activity. In searching for phosphorylation sites that could account for suppression of GC-B activity by S1P (sphingosine-1-phosphate), mutations were introduced into several candidate serine/threonine and tyrosine residues. Although no novel phosphorylation sites that influenced the suppression of GC-B were identified, experiments revealed that mutations in Tyr808 markedly enhanced GC-B activity. CNP-stimulated activities of the Y808F and Y808A mutants were greater than 30-fold and 70-fold higher, respectively, than that of WT (wild-type) GC-B. The Y808E and Y808S mutants were constitutively active, expressing 270-fold higher activity without CNP stimulation than WT GC-B. Those mutations also influenced the sensitivity of GC-B to a variety of inhibitors, including S1P, Na3VO4 and PMA. Y808A, Y808E and Y808S mutations markedly weakened S1P- and Na3VO4-dependent suppression of GC-B activity, whereas Y808E and Y808S mutations rather elevated cGMP production. Tyr808 is conserved in all membrane-bound GCs and located in the niche domain showing sequence similarity to a partial fragment of the HNOBA (haem nitric oxide binding associated) domain, which is found in soluble GC and in bacterial haem-binding kinases. This finding provides new insight into the activation mechanism of GCs.</jats:p> Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation Bioscience Reports
doi_str_mv 10.1042/bsr20130025
facet_avail Online
Free
finc_class_facet Biologie
Chemie und Pharmazie
Physik
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDEzMDAyNQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDEzMDAyNQ
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Portland Press Ltd., 2013
imprint_str_mv Portland Press Ltd., 2013
issn 1573-4935
0144-8463
issn_str_mv 1573-4935
0144-8463
language English
mega_collection Portland Press Ltd. (CrossRef)
match_str katafuchi2013mutationsintyr808revealapotentialautoinhibitorymechanismofguanylatecyclasebregulation
publishDateSort 2013
publisher Portland Press Ltd.
recordtype ai
record_format ai
series Bioscience Reports
source_id 49
title Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_unstemmed Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_full Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_fullStr Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_full_unstemmed Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_short Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_sort mutations in tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-b regulation
topic Cell Biology
Molecular Biology
Biochemistry
Biophysics
url http://dx.doi.org/10.1042/bsr20130025
publishDate 2013
physical
description <jats:p>In this study, Tyr808 in GC-B (guanylate cyclase-B), a receptor of the CNP (C-type natriuretic peptide), has been shown to be a critical regulator of GC-B activity. In searching for phosphorylation sites that could account for suppression of GC-B activity by S1P (sphingosine-1-phosphate), mutations were introduced into several candidate serine/threonine and tyrosine residues. Although no novel phosphorylation sites that influenced the suppression of GC-B were identified, experiments revealed that mutations in Tyr808 markedly enhanced GC-B activity. CNP-stimulated activities of the Y808F and Y808A mutants were greater than 30-fold and 70-fold higher, respectively, than that of WT (wild-type) GC-B. The Y808E and Y808S mutants were constitutively active, expressing 270-fold higher activity without CNP stimulation than WT GC-B. Those mutations also influenced the sensitivity of GC-B to a variety of inhibitors, including S1P, Na3VO4 and PMA. Y808A, Y808E and Y808S mutations markedly weakened S1P- and Na3VO4-dependent suppression of GC-B activity, whereas Y808E and Y808S mutations rather elevated cGMP production. Tyr808 is conserved in all membrane-bound GCs and located in the niche domain showing sequence similarity to a partial fragment of the HNOBA (haem nitric oxide binding associated) domain, which is found in soluble GC and in bacterial haem-binding kinases. This finding provides new insight into the activation mechanism of GCs.</jats:p>
container_issue 3
container_start_page 0
container_title Bioscience Reports
container_volume 33
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792325586088099852
geogr_code not assigned
last_indexed 2024-03-01T12:07:57.478Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Mutations+in+Tyr808+reveal+a+potential+auto-inhibitory+mechanism+of+guanylate+cyclase-B+regulation&rft.date=2013-06-01&genre=article&issn=1573-4935&volume=33&issue=3&jtitle=Bioscience+Reports&atitle=Mutations+in+Tyr808+reveal+a+potential+auto-inhibitory+mechanism+of+guanylate+cyclase-B+regulation&aulast=Katafuchi&aufirst=Takeshi&rft_id=info%3Adoi%2F10.1042%2Fbsr20130025&rft.language%5B0%5D=eng
SOLR
_version_ 1792325586088099852
author Katafuchi, Takeshi
author_facet Katafuchi, Takeshi, Katafuchi, Takeshi
author_sort katafuchi, takeshi
container_issue 3
container_start_page 0
container_title Bioscience Reports
container_volume 33
description <jats:p>In this study, Tyr808 in GC-B (guanylate cyclase-B), a receptor of the CNP (C-type natriuretic peptide), has been shown to be a critical regulator of GC-B activity. In searching for phosphorylation sites that could account for suppression of GC-B activity by S1P (sphingosine-1-phosphate), mutations were introduced into several candidate serine/threonine and tyrosine residues. Although no novel phosphorylation sites that influenced the suppression of GC-B were identified, experiments revealed that mutations in Tyr808 markedly enhanced GC-B activity. CNP-stimulated activities of the Y808F and Y808A mutants were greater than 30-fold and 70-fold higher, respectively, than that of WT (wild-type) GC-B. The Y808E and Y808S mutants were constitutively active, expressing 270-fold higher activity without CNP stimulation than WT GC-B. Those mutations also influenced the sensitivity of GC-B to a variety of inhibitors, including S1P, Na3VO4 and PMA. Y808A, Y808E and Y808S mutations markedly weakened S1P- and Na3VO4-dependent suppression of GC-B activity, whereas Y808E and Y808S mutations rather elevated cGMP production. Tyr808 is conserved in all membrane-bound GCs and located in the niche domain showing sequence similarity to a partial fragment of the HNOBA (haem nitric oxide binding associated) domain, which is found in soluble GC and in bacterial haem-binding kinases. This finding provides new insight into the activation mechanism of GCs.</jats:p>
doi_str_mv 10.1042/bsr20130025
facet_avail Online, Free
finc_class_facet Biologie, Chemie und Pharmazie, Physik
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDEzMDAyNQ
imprint Portland Press Ltd., 2013
imprint_str_mv Portland Press Ltd., 2013
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 1573-4935, 0144-8463
issn_str_mv 1573-4935, 0144-8463
language English
last_indexed 2024-03-01T12:07:57.478Z
match_str katafuchi2013mutationsintyr808revealapotentialautoinhibitorymechanismofguanylatecyclasebregulation
mega_collection Portland Press Ltd. (CrossRef)
physical
publishDate 2013
publishDateSort 2013
publisher Portland Press Ltd.
record_format ai
recordtype ai
series Bioscience Reports
source_id 49
spelling Katafuchi, Takeshi 0144-8463 1573-4935 Portland Press Ltd. Cell Biology Molecular Biology Biochemistry Biophysics http://dx.doi.org/10.1042/bsr20130025 <jats:p>In this study, Tyr808 in GC-B (guanylate cyclase-B), a receptor of the CNP (C-type natriuretic peptide), has been shown to be a critical regulator of GC-B activity. In searching for phosphorylation sites that could account for suppression of GC-B activity by S1P (sphingosine-1-phosphate), mutations were introduced into several candidate serine/threonine and tyrosine residues. Although no novel phosphorylation sites that influenced the suppression of GC-B were identified, experiments revealed that mutations in Tyr808 markedly enhanced GC-B activity. CNP-stimulated activities of the Y808F and Y808A mutants were greater than 30-fold and 70-fold higher, respectively, than that of WT (wild-type) GC-B. The Y808E and Y808S mutants were constitutively active, expressing 270-fold higher activity without CNP stimulation than WT GC-B. Those mutations also influenced the sensitivity of GC-B to a variety of inhibitors, including S1P, Na3VO4 and PMA. Y808A, Y808E and Y808S mutations markedly weakened S1P- and Na3VO4-dependent suppression of GC-B activity, whereas Y808E and Y808S mutations rather elevated cGMP production. Tyr808 is conserved in all membrane-bound GCs and located in the niche domain showing sequence similarity to a partial fragment of the HNOBA (haem nitric oxide binding associated) domain, which is found in soluble GC and in bacterial haem-binding kinases. This finding provides new insight into the activation mechanism of GCs.</jats:p> Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation Bioscience Reports
spellingShingle Katafuchi, Takeshi, Bioscience Reports, Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation, Cell Biology, Molecular Biology, Biochemistry, Biophysics
title Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_full Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_fullStr Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_full_unstemmed Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_short Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
title_sort mutations in tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-b regulation
title_unstemmed Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation
topic Cell Biology, Molecular Biology, Biochemistry, Biophysics
url http://dx.doi.org/10.1042/bsr20130025